摘要
目的探讨阿托品和复方托品酰胺在青少年散瞳验光中的实用价值。方法对青少年屈光不正患者40例,按年龄分为Ⅰ组(5-10岁)和Ⅱ组(11-20岁),每组各20例,40眼,对两组患者均行复方托品酰胺和1%阿托品散瞳后,对其验光结果进行对照观察。结果Ⅰ组两种药物有统计学意义,P<0.01。Ⅱ组两种药物无统计学意义,P>0.05。结论对于5-10岁屈光不正患者阿托品散瞳验光较准确,11-20岁屈光不正患者可以先用复方托品酰胺散瞳后验光。
Objective To study the effect of atropine and compound tropicamide in mydriatic refractometry of juvenile with ametropia. Methods Forty patients with ametropia were divided into two groups by age (Group Ⅰ , 5 - 10 years old, n = 40; Group Ⅱ, 11- 20 years old, n = 40). All eyes were examined by mydriatic refractometry after 1% atropine and compound tropicamide. Results There was a statistical difference in mydriatic refractometry between 1% atropine and compound tropicamide in group Ⅰ, but not in group Ⅱ. Conclusion Mydriatic refractometry using atropine is more accuract for the young patients with ametropia from 5 to 10 years old, but not necessary for the young patients with ametropia from 11 to 20 years old.
出处
《山西医科大学学报》
CAS
2007年第3期258-259,共2页
Journal of Shanxi Medical University
关键词
屈光不正
散瞳药
治疗结果
refractive errors
mydriatics
treatment outcome